CBD's brain protection after ischemia involved multiple receptor types in mice
In mice subjected to cerebral ischemia, CBD prevented anxiety, memory impairment, and depressive-like behavior through CB1, CB2, 5-HT1A, and PPAR-gamma receptors, with each receptor contributing to different aspects of recovery.
Quick Facts
What This Study Found
CBD prevented anxiety-like behavior, memory impairments, and despair-like behaviors after cerebral ischemia. The anxiolytic effects were attenuated by antagonists of CB1, CB2, 5-HT1A, and PPAR-gamma receptors. Both CBD and the CB1 antagonist AM251 improved spatial memory in ischemic animals, suggesting complex receptor interactions.
Key Numbers
CBD 10 mg/kg; 4 receptor antagonists tested (AM251, AM630, WAY-100635, GW9662); behavioral battery of 4 tests; all 4 receptor types contributed to anxiolytic effects
How They Did This
C57BL/6J mice underwent bilateral common carotid artery occlusion for 20 minutes. CBD (10 mg/kg) was administered before and after reperfusion. Receptor antagonists for CB1, CB2, 5-HT1A, and PPAR-gamma were given before each CBD injection. Behavioral testing included open field, elevated zero maze, Y-maze, and forced swim test.
Why This Research Matters
Understanding which receptors mediate CBD's neuroprotective effects is critical for developing targeted therapies. The finding that multiple receptor systems are involved explains why CBD has such broad neurological effects and suggests combination approaches might enhance efficacy.
The Bigger Picture
CBD's multi-receptor mechanism is both its strength and its challenge. The broad pharmacological profile may explain its diverse therapeutic effects across different conditions, but also makes it harder to predict or optimize for specific outcomes.
What This Study Doesn't Tell Us
Mouse model with pre-treatment design. Multiple receptor antagonists introduce pharmacological complexity. Behavioral tests are proxies for human conditions. Single dose of CBD tested.
Questions This Raises
- ?Would targeting specific receptor combinations produce better outcomes than CBD alone?
- ?Does the relative contribution of each receptor change with different CBD doses?
- ?How do these findings translate to human post-stroke recovery?
Trust & Context
- Key Stat:
- 4 receptor types (CB1, CB2, 5-HT1A, PPAR-gamma) mediated CBD's effects
- Evidence Grade:
- Well-designed mechanistic animal study with systematic antagonist approach, but mouse model and pre-treatment design limit clinical translation.
- Study Age:
- Published in 2021.
- Original Title:
- Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.
- Published In:
- The European journal of neuroscience, 53(6), 1738-1751 (2021)
- Authors:
- Mori, Marco Aurélio(4), Meyer, Erika(3), da Silva, Francielly F, Milani, Humberto, Guimarães, Francisco Silveira, Oliveira, Rúbia Maria Weffort
- Database ID:
- RTHC-03362
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does CBD protect the brain after ischemia?
This study found CBD works through at least four receptor systems: CB1 and CB2 cannabinoid receptors, the serotonin 5-HT1A receptor, and PPAR-gamma. Each contributed to reducing anxiety, though cognitive effects involved mainly CB1.
Could CBD help stroke patients?
These findings are from mice and cannot be directly applied to humans. Clinical trials would be needed to determine if CBD has similar neuroprotective effects in human stroke patients.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03362APA
Mori, Marco Aurélio; Meyer, Erika; da Silva, Francielly F; Milani, Humberto; Guimarães, Francisco Silveira; Oliveira, Rúbia Maria Weffort. (2021). Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.. The European journal of neuroscience, 53(6), 1738-1751. https://doi.org/10.1111/ejn.15134
MLA
Mori, Marco Aurélio, et al. "Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments.." The European journal of neuroscience, 2021. https://doi.org/10.1111/ejn.15134
RethinkTHC
RethinkTHC Research Database. "Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ re..." RTHC-03362. Retrieved from https://rethinkthc.com/research/mori-2021-differential-contribution-of-cb1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.